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Abstract
Background: Human tuberculosis (TB) in West Africa is not only caused by M. tuberculosis but also by bacteria of the two
lineages of M. africanum. For instance, in The Gambia, 40% of TB is due to infections with M. africanum West African 2. This
bacterial lineage is associated with HIV infection, reduced ESAT-6 immunogenicity and slower progression to active disease.
Although these characteristics suggest an attenuated phenotype of M. africanum, no underlying mechanism has been
described. From the first descriptions of M. africanum in the literature in 1969, the time to a positive culture of M. africanum
on solid medium was known to be longer than the time to a positive culture of M. tuberculosis. However, the delayed
growth of M. africanum, which may correlate with the less virulent phenotype in the human host, has not previously been
studied in detail.
Methodology/Principal Findings: We compared the growth rates of M. tuberculosis and M. africanum isolates from The
Gambia in two liquid culture systems. M. africanum grows significantly slower than M. tuberculosis, not only when grown
directly from sputa, but also in growth experiments under defined laboratory conditions. We also sequenced four M.
africanum isolates and compared their whole genomes with the published M. tuberculosis H37Rv genome. M. africanum
strains have several non-synonymous SNPs or frameshift mutations in genes that were previously associated with growth-
attenuation. M. africanum strains also have a higher mutation frequency in genes crucial for transport of sulphur, ions and
lipids/fatty acids across the cell membrane into the bacterial cell. Surprisingly, 5 of 7 operons, recently described as essential
for intracellular survival of H37Rv in the host macrophage, showed at least one non-synonymously mutated gene in M.
africanum.
Conclusions/Significance: The altered growth behaviour of M. africanum might indicate a different survival strategy within
host cells.
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Introduction
Mycobacterium africanum, a member of the Mycobacterium
tuberculosis complex, was first described in 1968 in Dakar,
Senegal [1]. Infections with M. africanum are generally
geographically restricted to human populations in West Africa,
and are not well understood [2]. Molecular techniques have
since refined the classification of the sub-species M. africanum
into M. africanum West African 1, common around the Gulf of
Guinea, and M. africanum West African 2, mainly found in
Western West Africa [3,4]. Although up to 30–40% of all
human tuberculosis in West Africa is caused by either of the two
M. africanum lineages [2], basic research on these clinically
important mycobacteria was neglected to date. However, an
improved understanding of the biology of this mycobacterial
lineage will also give clues about genetic functions in the closely
related M. tuberculosis.
The biochemical characteristics of M. africanum vary; at times,
they resemble those of M. bovis, and, at times, M. tuberculosis [5].
Clinically and epidemiologically, M. africanum behaves very
differently from M. tuberculosis. For instance, studies from The
Gambia showed that M. africanumWest African 2 is associated with
HIV infection [2], reduced ESAT-6 immunogenicity [6] and a
slower progression to active disease [7]. These features suggest an
overall attenuation of the bacterium, yet no underlying mechanism
has been identified to date. From the first descriptions of M.
africanum, the time to detection on solid medium was known to be
longer for M. africanum compared to M. tuberculosis. This delayed
growth, which may explain the reduced virulence of M. africanum,
has not previously been investigated.
We determined the bacterial growth rate of molecularly
characterized lineages of the M. tuberculosis complex collected
from The Gambia in two liquid culture systems, both directly from
sputum and in carefully controlled growth experiments. M.
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africanum West-African 2 (from now on referred to as M. africanum)
grows significantly slower than M. tuberculosis in all of the culture
systems we used. By comparisons of genetic sequence data, M.
africanum strains have several mutations in genes that were
previously associated with growth-attenuation in M. tuberculosis
H37Rv. This high mutation frequency was also observed in
functional groups of molecular membrane transport systems that
translocate macromolecules and nutrients across the cell mem-
brane into the bacterial cell. We conclude that the altered growth
behaviour of M. africanum may be a different survival strategy
within the host.
Materials and Methods
Mycobacterial growth curves from sputum and from
standardized inoculum
In the context of several TB cohort studies, we collected clinical
isolates from patients with smear positive pulmonary TB. Each TB
patient submitted up to three sputum samples. Sputum was
decontaminated using NALC-NaOH and inoculated into either
BACTEC MYCO/F-Sputa vials (for the BACTEC 9000, BD)
and/or BACTEC MGIT 960 Tubes supplemented with PANTA
(for BACTECMGIT 960, BD). The tubes were incubated at 37uC
and the ‘‘Time to Positivity’’ (manufacturer-set threshold: 75
Growth Units) was recorded in days. Tubes were incubated for a
maximum of 42 days.
In a second experiment we compared the growth rates of M.
tuberculosis laboratory strain Mt14323 [8] and clinical M.
africanum isolate ITM 080552 in a controlled laboratory setting,
using defined inocula. For each strain, a standardized inoculum
was prepared from a fresh subculture of 21 days with a turbidity
of McFarland Nu 0.5. The OD492 nm and OD595 nm were
measured and the bacterial suspension was adjusted to
OD= 0.01–0.03. A dilution of 1:10 was prepared in distilled
water. From this dilution we made a half logarithmic dilution
series and 100 ml of each dilution was inoculated in triplicate
into MGIT960. To estimate colony-forming-units (CFU) each
inoculum was plated on 7H11 plates. Growth curves were
monitored using the BD Epicentre software, data were
extracted, and the length of the lag phase or ‘‘Time to
Positivity’’ for each strain to reach the ‘‘positivity threshold’’
of 75 growth units (GU) was measured. Furthermore, the actual
growth rate or doubling time was determined as the time needed
for a strain to grow from 5000GU to 10000GU. We used the
non-parametric Wilcoxon rank sum test to compare the median
time to positivity for M. tuberculosis versus M. africanum.
Ethical statement
The samples used are all from the MRC strain collection, which
comprises strains from various studies that were conducted over
the last years. All these studies obtained ethical approval, informed
consent from patients and samples were anonymized.
Genotyping mycobacterial isolates
Genotyping was done using spoligotype analysis [9] and PCR
for Large Sequence Polymorphisms [4] on the mycobacterial
DNA from one isolate from each patient, with the assumption that
all samples from the same patient contained the same mycobac-
terial isolate. Isolates were grouped in phylogenetically distinct
lineages within the M. tuberculosis complex, as previously defined
[4].
Next generation sequencing for whole bacterial
genomes
We sequenced the genomes of four M. africanum West Africa 2
isolates, three that originated from The Gambia and one publicly
available strain from Senegal. We re-sequenced the published
strain GM041982 [10], two randomly selected Gambian isolates
03/03910 and 03/030671 from MRC’s strain collection, and
strain ATCC 35711.
Library preparation. 2.5 mg of genomic DNA products of
each sample were combined and fragmented into a peak size range
of 200–400 bp using the Covaris S2 (Covaris, Woburn, MA, USA)
(shearing conditions - Duty cycle: 20%; Intensity: 4; Cycles per
burst: 200; Time: 360 seconds). After fragmentation, the samples
were purified using the Qiagen PCR purification kit (Qiagen,
Valencia, CA, USA). Fragmented products were quality-checked
(2100 Bioanalyzer on a DNA 1000 Chip, Agilent Technologies,
Santa Clara, CA, USA). The NEB Next DNA Sample Prep
Master Mix kit (New England Biolabs, Ipswich, MA, USA) was
used. Library preparation entailed: end-repair, A-tailing and
ligation of adapters according to the manufacturer’s instructions.
Size selection was conducted on a Pipen Prep from Sage Science,
fragments in the range 300–500 bp were selected. Then a quality-
check of the size selected product was run on the 2100 Bioanalyzer
(DNA High Sensitivity DNA Chip). Finally, using the Multiplexing
Sample Preparation Oligonucleotide Kit (Illumina, San Diego,
CA, USA), samples underwent 14 PCR cycles to incorporate
indexes followed by Agencourt AMPure XP magnetic bead
(Beckman Coulter, Brea, CA, USA) clean up according to
manufacturer’s instructions. One more quality check was con-
ducted using the Bioanalyzer with a run on a DNA 1000 Chip,
and all samples were adjusted to a final concentration of 10 nM. A
qPCR step was performed to ensure all material sent for
sequencing contained the adaptors and indexes. We used the
LightCycler 480 SYBR Green I Master mix (Roche Applied
Science, Indianapolis, IN, USA) in a LightCycler 480 II real time
thermal cycler (Roche Applied Science, Indianapolis, IN, USA)
according to the manufacturer’s instructions.
Multiplexed sequencing. Next generation sequencing was
done using Illumina Hiseq 2000 flow cell, 2676 base pair-end
runs. PhiX was used as control. Sequencing was carried out by
Author Summary
Mycobacterium tuberculosis and Mycobacterium africanum
are the two major lineages within the M. tuberculosis
complex that cause human tuberculosis in West Africa.
Despite being closely related, the outcome after infection
differs between these two pathogens. Although M.
africanum has not yet been studied to the same extent
as M. tuberculosis, M. africanum is less likely to stimulate
the host immune system or to progress to active disease.
We hypothesized that this somewhat attenuated pheno-
type is due to the slower growth of M. africanum within
the host. Therefore, we analysed clinical isolates from 522
patients with tuberculosis in The Gambia. M. africanum
West Africa 2 strains grew more slowly than M. tuberculosis.
We sequenced four M. africanum strains and identified
several candidate genes that may cause the growth-
attenuation of the bacteria. Describing the fundamental
genomic and phenotypic differences between M. tubercu-
losis and M. africanum will enable us to better understand
the virulence mechanisms that make M. tuberculosis one of
the most successful bacterial pathogens, and to discover
potential strategies to interfere with mycobacterial path-
ogenicity.
Growth-attenuation of Mycobacterium africanum
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Genome Technology Biology team in Genome Institute of
Singapore.
Analysis of whole genome sequences. Unix Korn Shell
was used to access the server and perform the analysis. Scripts
written by the bioinformatics team in GIS were used to do
assembly, call SNPs and build a phylogeny tree for the sample set.
CLC Genomics was used to visualize quality of the reads, mapped
SNPs and align sequences.
Genetic comparison of M. tuberculosis H37Rv and M.
africanum
We compared selected genes from the M. tuberculosis H37Rv
genome [11] with their respective homologues of the sequenced
M. africanum strains. We only considered single nucleotide
polymorphisms (SNPs) or deletion/insertion polymorphism
(DIPs) that were common to all four M. africanum strains. Genes
that were only mutated in some of the sequenced strains were
considered to be uncommon to M. africanum and were considered
wildtype genes. The analysed set of genes which is responsible for
attenuated growth in vitro was extracted from a previous
publication [12]. Genes and operons essential for in vivo growth
within macrophages were recently published [13]. Genes
encoding nutrient and macromolecule transport mechanisms
were identified from the literature [14–17] and by a NCBI
PubMed search. Additionally, genes annotated as transporters
were identified in the TubercuList database (http://tuberculist.
epfl.ch/). In both searches, genes encoding transport proteins
with unknown substrate specificity or annotated drug/antibiotic
efflux pumps were excluded from the analysis. To compare the
proportion of genes carrying non-synonymous SNPs between
groups the Fisher’s exact test was conducted and the results were
considered significant at the level of p#0.05, assuming the
likelihood of a Type I error was a=0.05.
Predicting the impact of non-synonymous mutations on
protein function
To understand whether an amino acid substitution affected
protein function inM. africanum, we conducted an analysis using the
SIFT (‘‘Sorting Intolerant from Tolerant’’) Sequence algorithm
(http://sift.bii.a-star.edu.sg/www/SIFT_seq_submit2.html) [18].
The parameters were used at their default setting and the
gene sequences and respective substitutions were analysed
using the ‘‘UniProt-SwissProt+TrEMBL 2010_09 database’’ as
reference.
Results
Growth curves from sputum
Among isolates from 552 TB cases the prevalence of M.
africanum West Africa 2 (n = 223) was 40%, consistent with
previously reported results [19]. From these 552 patients a total
of 1333 positive cultures (M. tuberculosis n= 823, M. africanum
n=510) were obtained and analysed in the study (Figure 1). In
both liquid culture systems, the median time to culture positivity
was significantly shorter for M. tuberculosis (Bactec 9000: 13d,
MGIT960: 9d) relative to M. africanum (Bactec 9000: 21d,
MGIT960: 15d) (see Table 1 and Fig. 2).
Figure 1. Culture methods and spoligotyping results from isolates obtained from sputum samples of 552 patients in the study.
doi:10.1371/journal.pntd.0002220.g001
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Growth curve from standardized inoculum
To further compare the growth dynamics of the two lineages,
we inoculated 5.96103 CFU/ml and 8.36103 CFU/ml of M.
tuberculosis and M. africanum, respectively, into MGIT tubes and
incubated them at 37uC. The lag phase or ‘‘time to positivity’’ was
175.2 hours (7.30 days) for M. tuberculosis strain Mt14323 and
213.00 hours (8.88 days) for M. africanum strain ITM 080552.
Furthermore, we determined the doubling time of M. tuberculosis to
be 20.16 h, in contrast to the doubling time of 24.12 h for M.
africanum (see Figure 3).
Genetic comparison of M. tuberculosis H37Rv and M.
africanum
Growth attenuating genes. Based on transposon insertion
and gene-disruption, a set of 42 growth-attenuating genes was
previously identified [12]. Each of these genes resulted in growth-
attenuation when inactivated through transposon insertion. In our
study, 12 of the 42 growth-attenuating genes had non-synonymous
mutations, and 4 of these genes were affected in their protein
function as predicted by SIFT analysis. For a detailed list of the
genes and their mutations see table 2.
Essential genes. M. tuberculosis genes were previously clas-
sified into two groups: essential or non-essential for in vitro growth
[12].We selected the 614 essential genes described for M.
tuberculosis H37Rv and genetically compared them with their
respective homologues in M. africanum. We found that 132 (21%)
of 614 essential M. africanum genes contained non-synonymous
mutation(s) which resulted in an amino acid change within the
respective proteins. We considered the 21% percentage difference
to be the baseline difference between the genomes of M.
tuberculosis H37Rv and M. africanum (see Table 3).
Transporter genes. We identified a total of 132 genes that
were common to both M. tuberculosis H37Rv and M. africanum
and that were described or annotated as genes encoding
structural components of membrane transporters from the
literature and publicly available databases. The 132 genes
included transporters specific for nutrients as well as for the
transport of macromolecules. We found that M. africanum genes
encoding sulphur transporters, ion transporters and fatty acids
transporters were significantly more likely to carry a non-
synonymous mutation than essential M. africanum genes (see
Table 3 and Figure 4). No such effect was observed in genes
Figure 2. Frequency distributions for the Time-to-Positivity of mycobacterial cultures in two liquid culture systems. All samples were
incubated for 42 days. Upper panels: results for the Bactec 9000, Lower panels: Bactec MGIT 960, solid bars: M. tuberculosis, open bars: M. africanum.
doi:10.1371/journal.pntd.0002220.g002
Table 1. Growth of M. tuberculosis complex isolates from
sputum in The Gambia in two liquid culture systems.
Bactec 9000 Bactec MGIT
M. africanum
Number of cultures 393 117
Median days to growth 21 15
Range 2–42 2–40
M. tuberculosis
Number of cultures 593 230
Median days to growth 13 9
Range 2–42 1–22
P value* ,0.00005 ,0.00005
*Wilcoxon rank sum test comparing median time for M. africanum vs. M.
tuberculosis.
doi:10.1371/journal.pntd.0002220.t001
Growth-attenuation of Mycobacterium africanum
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encoding carbohydrate, amino acid or peptide transporters.
Interestingly, we found transporter systems specific for nitrogen
were hyper- conserved and were less likely to be mutated when
compared with essential genes.
Genes essential for intracellular survival. We studied a
group of 7 operons that were previously described as crucial for
the intracellular survival of M. tuberculosis H37Rv in macrophages
[13]. We found that five out of seven operons had at least one
mutated gene in M. africanum (see Fig. 5). Although the pstA1 gene
of the phosphate transport operon was mutated in M. africanum
GM041182 and ATCC35711, this was not a common trait of all
analysed M. africanum strains.
Discussion
M. africanum grows slower than M. tuberculosis, with delayed
culture positivity (by 4–6 days) when grown from sputum in
modern liquid culture systems. Although these liquid culture
systems are only indirectly measuring growth by detecting oxygen
or radioactive precursor consumption as a proxy for growth, they
are well suited to compare the growth behaviour of different
bacterial isolates. The observed growth differences between the
two lineages were further emphasized by a survival analysis which
was adjusted for smear grade, and we estimated a Hazard ratio
(HR)= 0.40 (95%CI 0.35–0.47, p,0.0005). Consistent with this
Figure 3. In vitro growth curves from standardized inocula. M. tuberculosis (solid line) and M. africanum (dashed line) were grown from
standardized inocula in Bactec MGIT 960 and measured growth units (GU) are plotted versus time [days].
doi:10.1371/journal.pntd.0002220.g003
Growth-attenuation of Mycobacterium africanum
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diagnostic observation, we determined a longer doubling time of
M. africanum in growth experiments in which the inoculum was
carefully standardized by CFU. One limitation of this approach is
that it is not clear whether cording differs between M. africanum
and M. tuberculosis, which could potentially impact on CFU
standardization. Also testing a wider range of isolates together with
comparative genomics could enhance the power of the in vitro
experiments in the future. However, both our findings on growth
from sputum and standardized inoculum are consistent with other
studies, as the measured doubling times for both of the lineages
were in the same range as previously described by Bold et al. [20].
Our results also reproduced the initial observations from Senegal
in 1968, when isolates, identified as M. africanum by biochemical
methods, yielded growth on solid media later than M. tuberculosis
isolates [1]. Therefore, Castets in 1979 recommended incubation
for 90 days for the detection of M. africanum on solid media [21].
However, with the advent of modern automated liquid culture
systems, the original recommendations need to be adjusted and
redefined. For the current study, we incubated all samples for 42
days, as recommended by the manufacturer of the liquid culture
systems. Although 42 days are sufficient to detect M. tuberculosis
strains, the frequency distributions indicated that for M. africanum
strains a longer incubation period might be advisable. For
instance, in the Bactec 9000, only seven cultures turned positive
on the very last day of the incubation period. For this reason, the
Bactec MGIT960 seems preferable and better suited for the
cultivation of M. africanum, as overall incubation times decreased
and detection of culture positivity can be achieved faster.
Therefore to evaluate the potential of these liquid cultures systems
as diagnostic tools for M. africanum detection, further long-term
growth studies need to determine the maximum M. africanum -
specific incubation times. Such studies could also evaluate whether
the currently applied incubation protocols resulted in an
underestimation of M. africanum prevalence or failed to detect
mixed infections.
The selective advantage of the growth delay of M. africanum is
not clear. However comparison of the genome sequences of M.
tuberculosis H37Rv and M. africanum give some clues to the
underlying mechanisms. First, we investigated a group of genes,
each of which has already been described to result in in vitro
growth-attenuation of M. tuberculosis H37Rv upon transposon
(TraSH) inactivation [12]. Of 42 growth-attenuating genes, 12
genes contained non-synonymous mutations or were pseudogenes
due to frameshift mutations in M. africanum. In particular, 4 gene
products (Rv2112c/MAF_21240, Rv0862c/MAF_08710, AceE,
RecA) were predicted by SIFT analysis to be affected in their
protein function. These four proteins are the most likely
candidates responsible for the observed growth attenuation in M.
africanum. A fifth identified gene, glpK, is a pseudogene in
GM041182 or with non-synonymous mutations in the other 3
strains, yet SIFT analysis identified the amino acid substitution to
be tolerated by the bacteria. Therefore the Glpk protein is most
likely functional in 3 out of 4 M. africanum strains and is not a
common cause for the observed, slower growth.
We further hypothesized that a reduction and/or deficiency of
molecular membrane transporters could limit growth of M.
africanum. For instance, the knock-out of outer membrane Msp
porins and a subsequent reduced sugar and phosphate uptake led
to a slower growth rate of M. smegmatis [22]. Similarly it was
previously suggested that the slower growth of M. tuberculosis, when
compared to the fast-growing Mycobacterium smegmatis, could be due
to the loss of several sugar transporters [17]. Therefore we aimed
to determine the status of known transport mechanisms in the
sequenced M. africanum genomes and M. tuberculosis H37Rv.
We identified 132 membrane transporter genes common to the
two mycobacterial lineages. In M. africanum, there were signifi-
Table 2. List of growth-attenuating genes with non-synonymous or frameshift mutations in M. africanum.
Gene
name
H37Rv
MAF
homologue Product/Function Mutation in MAF
Amino acid
change in
MAF SIFT analysis
Rv0862c MAF_08710 Conserved protein/Function unknown C480A, T2246C None,
L749V
Affects protein
function
Rv1096 MAF_11110 Possible Glycosyl Hydrolase/Probably involved in
Carbohydrate degradation
C814T P272S -
Rv1125 MAF_11410 Conserved hypothetical protein/Function unknown A301G, G855C, T897C S101G -
Rv1178 MAF_11970 Probable Aminotransferase/Function unknown C741T, C953T A318V -
glgP glgP Probable Glycogen phosphorylase/Allosteric enzyme in
carbohydrate metabolism
G2192A, G2401T G731D,
A801S
-
Rv1592c MAF_16040 Conserved hypothetical protein/Function unknown A963G, A964G I322V -
Rv2112c MAF_21240 Deamidase/Deamidates the C-terminal Glutamine
of PUP
C20G, C1499T P7R, A500V Affects protein
function (low
confidence)
aceE aceE Pyruvate Dehydrogenase E1 component/involved
in energy metabolism
G2329A A777T Affects protein
function
mbtB mbtB Phenyloxazolin synthase/Biogenesis of the Hydroxyphenyl-
oxazoline-containing siderophore mycobactins
C2932T L978V -
recA recA Recombinase A/Nucleotide Excision Repair A1697C Q566P Affects protein
function
Rv3282 MAF_32920 Conserved hypothetical protein/Function unknown C434A T145K -
glpK glpK Probable Glycerol Kinase/Glycerol utilization T1379C, (Pseudo-gene
in GM041182)
V460A,
(Pseudo-gene
in GM041182)
(Pseudogene in
GM041182)
doi:10.1371/journal.pntd.0002220.t002
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cantly more genes encoding sulphur/sulphate-, lipid/fatty-acid,
and ion-transporter with non-synonymous or frameshift mutation
than in essential genes.
Although sulphur is an essential nutrient for mycobacterial
survival and virulence (for review see [16,23]), we identified
(protein function affecting, SIFT) mutations in the cysTWA/subI
ABC-transporter of M. africanum. Since subI-knock out mutants of
M. bovis were restricted in their sulphate uptake [24], it is
conceivable that M. africanum strains are similarly impaired in their
import of sulphur. Although there was speculation that Rv1739c,
another predicted sulphate transporter [25] could compensate for
the loss of the cysTWA/subI transport system [26], it is unlikely
because this protein is likewise potentially inhibited in its protein
function due to a SNP mutation. Whether the hypothetical
sulphate-transporter Rv1707, which carries a tolerated amino acid
change in M. africanum, is a functional sulphate transport
mechanism still has to be experimentally confirmed.
A second group of highly mutated M. africanum genes encode for
ion transport mechanisms. Unfortunately, the knowledge about
this important group of proteins is still scarce [14]. However,
KefB, a potassium/proton antiporter that controls the early
acidification of the phagosome, was mutated and impaired in its
protein function (SIFT) in M. africanum [27]. Also, knock-out
mutants of the Mg2+-transporter MgtC, which is potentially
affected in its protein function (SIFT) inM. africanum, had impaired
growth under certain in vitro conditions [28]. Another group of
heavy-metal ion transporter genes in M. tuberculosis, ctpA-ctpV, are
very different in M. africanum. For instance ctpV, one of the best
studied members of this family, yet with a tolerated (SIFT)
mutation in M. africanum, is key for mycobacterial copper
homeostasis and virulence [29]. Similarly, the iron-specific ABC-
transporter IrtAB, in which the IrtA subunit has an intolerable
amino acid substitution (SIFT) in M. africanum, is not only crucial
for survival in iron-deficient conditions, but is also required to
effectively establish infection in the experimental murine host [30].
Most importantly, all the above mentioned ion transporter genes
have one thing in common: they were found to play key roles in
the intracellular survival of the bacteria within the phagolysosome
of macrophages [27–30]. It is surprising that genes important for
this crucial step of mycobacterial pathogenesis were among the
least conserved in M. africanum, which could indicate that M.
africanum might pursue a different intracellular survival strategy
than M. tuberculosis to cope with the harsh environment within a
phagolysosome.
Therefore we investigated 7 putative operons that were
previously described as essential for the intracellular survival of
M. tuberculosis H37Rv in macrophages [13]. Components of the
sugar transport system (sugA/B/C/lpqY) were hyperconserved
among the M. africanum isolates. Similarly, with the exception of
pstA1, all M. africanum genes encoding phosphorous transporters
were conserved amongst the sequenced isolates. Our results
suggest that both pathways are equally important for M. tuberculosis
and M. africanum. However, we found a remarkable difference
between the two lineages. In the course of host macrophage
infection, lipids become increasingly more important and replace
carbohydrates as the major carbon source [17], and 3 operons of
lipid metabolism (Rv3540c–Rv3545c, Rv3550–Rv3552, Rv3569c–
Rv3570c) were described to be required for mycobacterial survival
[13]. Interestingly, all of these operons have at least one mutated
gene in M. africanum. Consistently, 8/14 mmpL genes, that likely
transport lipids/fatty acids across the membrane, have altered
amino acid sequences, including a frameshift mutation in mmpL13a
that results in a pseudogene. Of note, mmpL3, which is one of 5
conserved mmpL genes in the obligate intracellular M. leprae, was
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shown to be the only gene of this family to be essential for viability
of M. tuberculosis [31]. However, mmpl3 is potentially affected in its
protein function (SIFT analysis) in M. africanum. Other genes,
essential for survival in macrophages, belong to a putative operon
spanning from Rv3864 to Rv3878 [13], a genetic region that
partially includes the RD1 locus encoding the ESX-1 secretion
system and its virulence genes such as esxA (encoding ESAT-6) and
esxB (encoding CFP-10). One of the genes, Rv3864 (espE), had a
non-synonymous SNP in one M. africanum isolate and a frameshift
mutation in the remaining three sequenced M. africanum strains.
This is interesting as Rv3864 was associated with virulence, yet it is
assumed that a loss of the gene can be compensated by its
homologue Rv3616 (espA) [32]. However, as the Rv3616 (espA)
homologue has a non-synonymous mutation inM. africanum as well
(data not shown), it is possible that none of these genes is functional
in M. africanum. This is supported by the previous finding that
certain M. africanum isolates were less likely to induce an ESAT-6
dependent IFN-c host response and it was speculated that this was
due to an ESAT-6 secretion impairment [6]. Combining the
finding that the Rv3864/espE homologue in M. marinum is required
for secretion of CFP-10 [32], and CFP-10 contains the secretion
signal of the ESAT-6/CFP-10 dimer [33], an inactive Rv3864/
espE could therefore be the missing genetic link to explain the
reduced ESAT-6 secretion of M. africanum. Finally, the seventh
operon under study, Rv0169–Rv0178, is essential for entry into the
mammalian cell and intracellular survival, yet several members are
highly mutated in M. africanum. Interestingly, the overall regulator
of this operon, Rv0165 (mce1R), has a frameshift mutation in M.
africanum (data not shown) and recent studies suggest that Mce1R is
part of a global genome-wide regulatory network which control
cell growth [34].
In the present study we found that M. africanum strains are
impaired in their capacity to grow. We identified several potential
gene candidates and functional protein groups that might
contribute to the observed growth defect. To unambiguously
confirm causality, complementation experiments in which the M.
Figure 4. Schematic overview of molecular transport mechanisms present in M. africanum. Genetic information of 132 genes encoding
various families of membrane transporters was compared between the sequenced M. africanum strains and M. tuberculosis H37Rv. The analysis
comprised both, transport mechanisms specific to nutrients and macromolecules (upper and lower figure). Genes that are identical to the wildtypeM.
tuberculosis H37Rv gene homologue are displayed with a solid border line and white background. Genes, with non-synonymous mutation are
displayed in blue with dashed lines. Genes with a frameshift mutation, are displayed with striped background.
doi:10.1371/journal.pntd.0002220.g004
Figure 5. Status of putative M. africanum operons essential for intracellular survival. Seven operons were previously defined as essential
for growth within the macrophage [13]. Genes that are identical to the wildtype M. tuberculosis H37Rv gene homologue are displayed with a solid
border line and white background. Genes, with a non-synonymous mutation are displayed in blue with dashed lines. Genes with a frameshift
mutation, are displayed with striped background.
doi:10.1371/journal.pntd.0002220.g005
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africanum mutant genes are replaced by wildtype H37Rv genes will
have to be conducted. However, our genomic analysis suggests
that the underlying genetic reason for the growth defect is rather
complex. The growth attenuation might be a redundant result due
to the loss of multiple genes. Moreover, large scale genomic
analyses on additional M, africanum genomes will have to be
conducted to confirm which of the described SNPs are really
specific to all members of the M. africanum West Africa 2 lineage.
Taken together, from a genetic and phenotypic point of view M.
africanum appears to be distinct from M. tuberculosis. M. africanum
may have a modified, yet unknown, survival strategy of the
bacterium within the human host. Future research on the lifestyle
of M. africanum may lead to an improved understanding of growth
promoting factors in M. tuberculosis and may ultimately reveal new
strategies to interrupt bacterial growth and replication within the
human host.
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